Clinical Trial Update: To Determine Tolerability to Glucagon Infusion in Obese Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study assessing tolerability of glucagon infusion in obese subjects; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• GLUCAGON (GLUCAGON)

Snippet

Sponsor: AdventHealth Translational Research Institute | Conditions: Obesity | Phase 1 | Status: ACTIVE_NOT_RECRUITING